away from the ris k of inheriting the same mutation,
the ethically alert society may consider such
molecular therapeutic intervention essential.
R ef er en ces :
1. Kay, Mark, David Schowalter. Gene
therapy: A status report. Pediatric Annals.
1997; 26.9 : 562-568
2. Wickelgren, I ngrid. New lead to safer
marrow transplants. Science Magazine.
1997; 276.5319 : 1646
3. Cole-Strauss, Allyson, Shanzhang Ye, Bruce
Frank, Eric Kmiec. Targeted gene
correction: A new strategy for molecular
medicine. Molecular Medicine T oday. 1998;
1357.4310 : 431-437
4. Lashford, Linda. Possibilities of gene
therapies for cancer. Annals of Medicine.
1997; 29 : 1-4
5. Peters, Richard, Robert Sikorsky. Treating
with HIV. S cience Magazine. 1 998;
282.5393: 1438
6. Miyoshi, Hiroyuki, Kent Smith, Donald
Moiser, I nder Verma, Bruce Torbett.
Transduction of human CD34+ cells that
mediate long-term engraftment of
NOD/S CI D mice by HIV vectors . Science
Magazine. 1999; 283.5402: 682-686
7. Couzin, Jennifer. RAC confronts in utero
gene therapy proposals. S cience Magazine.
1998; 282.5386: 27
8. Gardner , Phyllis, John Wagner . Toward
cystic fibrosis gene therapy. Annu. Rev.
Med. 1997; 48: 203-216